The smart pills market size has grown rapidly in recent years. It will grow from $6.11 billion in 2025 to $6.75 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, rising need for patient compliance monitoring, expansion of digital health initiatives, availability of advanced ingestible sensors, growing clinical research adoption.
The smart pills market size is expected to see rapid growth in the next few years. It will grow to $10.13 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing demand for personalized medicine solutions, rising investments in digital therapeutics, expansion of remote patient monitoring, growing adoption of smart drug delivery platforms, increasing regulatory support for connected health technologies. Major trends in the forecast period include increasing adoption of sensor-enabled drug delivery systems, rising focus on medication adherence solutions, growing integration with mobile health platforms, expansion of smart ingestible diagnostics, enhanced development of miniaturized electronics.
The increasing preference for non-invasive procedures is anticipated to drive the growth of the smart pills market in the coming years. Non-invasive procedures do not involve incisions or tissue removal, thereby reducing patient risk and shortening recovery time. The growing preference for non-invasive approaches is attributed to their ability to deliver effective diagnostic and therapeutic outcomes while minimizing physical burden on patients. Smart pills support non-invasive procedures by enabling internal imaging and physiological monitoring without the need for surgical entry, allowing clinicians to collect diagnostic information through a simple swallowable device. For example, in March 2024, according to NHS England, a UK-based public health service, more than 5,400 patients benefited from colon capsule endoscopy pill-cam pilot programs across 53 sites. Therefore, the rising preference for non-invasive procedures is contributing to the expansion of the smart pills market.
The increasing healthcare expenditure is anticipated to drive the growth of the smart pills market in the coming years. Healthcare expenditure refers to the overall spending on medical services, treatments, infrastructure, research, and public health programs aimed at maintaining or improving health outcomes. The rising demand for healthcare expenditure is attributed to the growing prevalence of chronic mental health conditions, which necessitate ongoing treatment, medication, and long-term care support. Healthcare expenditure facilitates the advancement of smart pills by financing innovative technologies that improve drug delivery, monitoring capabilities, and patient adherence. For example, in December 2024, according to the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, national health expenditures (NHE) increased by 7.5% to reach $4.9 trillion in 2023, representing 17.6% of gross domestic product (GDP). Furthermore, from 2023 to 2032, average national health expenditures (NHE) are expected to grow at an annual rate of 5.6%, leading to an increase in the healthcare spending share of GDP from 17.3% in 2022 to 19.7% in 2032. Thus, the rising healthcare expenditure is fueling the growth of the smart pills market.
Major companies operating in the smart pills market are concentrating on the development of smart pills with customizable programs, including ingestible multi-sensor prototypes that support tailored drug delivery and in-vivo monitoring to improve treatment adherence and therapeutic outcomes. Customizable programs refer to firmware- or software-based control of sensing functions, data collection, and triggerable actions that clinicians or trial managers can configure for individual patients. For example, in 2025, the Interuniversity Microelectronics Centre, a Belgium-based research and innovation institute, introduced a prototype ingestible sensor for gut health monitoring that integrates multiple sensing modalities chemical, mechanical, and electrical along with onboard signal processing, power management, and real-time data transmission for remote monitoring. The prototype focuses on miniaturization and full-system integration to enable configurable sensing programs for personalized clinical applications.
Major companies operating in the smart pills market are Medtronic plc, Olympus Corporation, CapsoVision Inc., Novartis AG, Proteus Digital Health Inc., Koninklijke Philips N.V., MicroCHIPS Inc., Bio-Images Drug Delivery (BDD) Ltd., Given Imaging Ltd., Vitality Inc., Boston Scientific Corporation, HQ Inc., Fujifilm Holdings Corporation, General Electric Company, Check-Cap Ltd., IntroMedic Co. Ltd., Jinshan Science & Technology Co. Ltd., PENTAX Medical, etectRx Inc., Pixie Scientific HQ Inc., ANX Robotica Corp., RF Co. Ltd., Shenzhen Jifu Medical Technology Co. Ltd., Otsuka America Pharmaceutical Inc., Medimetrics Personalized Drug Delivery B.V., Smart Pill Inc., Medisafe Inc., AdhereTech LLC, TabSafe Medical Services Inc.
North America was the largest region in the smart pills market in 2025. Western Europe was the second-largest region in the smart pills market analysis. The regions covered in the smart pills market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the smart pills market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the smart pills market by increasing costs of imported microelectronics, sensors, transmitters, and pharmaceutical-grade materials used in ingestible devices. Healthcare providers and research institutions in North America and Europe are most affected due to reliance on imported electronic components, while Asia-Pacific faces cost pressure on device manufacturing and exports. These tariffs are raising development and production costs and slowing commercialization timelines. However, they are also encouraging localized electronics manufacturing, domestic R&D investments, and regional partnerships to advance smart pill innovation.
The smart pills market research report is one of a series of new reports that provides smart pills market statistics, including smart pills industry global market size, regional shares, competitors with a smart pills market share, detailed smart pills market segments, market trends and opportunities, and any further data you may need to thrive in the smart pills industry. This smart pills market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Smart pills are designed for the purpose of administering medication and are equipped with electronic sensors that emit signals detectable by patches or smartphones upon ingestion. These innovative pills play a crucial role in ensuring patients' adherence to their prescribed drug regimens and enable the monitoring of medication compliance.
The primary applications of smart pills encompass capsule endoscopy, patient monitoring, and drug delivery. Patient monitoring involves the repeated or continuous tracking of various patient parameters. Smart pills are used to target specific areas within the gastrointestinal tract, including the esophagus, stomach, small intestine, and large intestine, for the treatment of conditions such as esophageal diseases, colon diseases, small bowel diseases, among others. These smart pills find utility in a variety of healthcare settings, including hospitals, diagnostic centers, and research institutes.
The smart pills market consists of sales of instruments that are used in applications such as capsule endoscopy, drug delivery, and patient monitoring. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The smart pills market size is expected to see rapid growth in the next few years. It will grow to $10.13 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing demand for personalized medicine solutions, rising investments in digital therapeutics, expansion of remote patient monitoring, growing adoption of smart drug delivery platforms, increasing regulatory support for connected health technologies. Major trends in the forecast period include increasing adoption of sensor-enabled drug delivery systems, rising focus on medication adherence solutions, growing integration with mobile health platforms, expansion of smart ingestible diagnostics, enhanced development of miniaturized electronics.
The increasing preference for non-invasive procedures is anticipated to drive the growth of the smart pills market in the coming years. Non-invasive procedures do not involve incisions or tissue removal, thereby reducing patient risk and shortening recovery time. The growing preference for non-invasive approaches is attributed to their ability to deliver effective diagnostic and therapeutic outcomes while minimizing physical burden on patients. Smart pills support non-invasive procedures by enabling internal imaging and physiological monitoring without the need for surgical entry, allowing clinicians to collect diagnostic information through a simple swallowable device. For example, in March 2024, according to NHS England, a UK-based public health service, more than 5,400 patients benefited from colon capsule endoscopy pill-cam pilot programs across 53 sites. Therefore, the rising preference for non-invasive procedures is contributing to the expansion of the smart pills market.
The increasing healthcare expenditure is anticipated to drive the growth of the smart pills market in the coming years. Healthcare expenditure refers to the overall spending on medical services, treatments, infrastructure, research, and public health programs aimed at maintaining or improving health outcomes. The rising demand for healthcare expenditure is attributed to the growing prevalence of chronic mental health conditions, which necessitate ongoing treatment, medication, and long-term care support. Healthcare expenditure facilitates the advancement of smart pills by financing innovative technologies that improve drug delivery, monitoring capabilities, and patient adherence. For example, in December 2024, according to the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, national health expenditures (NHE) increased by 7.5% to reach $4.9 trillion in 2023, representing 17.6% of gross domestic product (GDP). Furthermore, from 2023 to 2032, average national health expenditures (NHE) are expected to grow at an annual rate of 5.6%, leading to an increase in the healthcare spending share of GDP from 17.3% in 2022 to 19.7% in 2032. Thus, the rising healthcare expenditure is fueling the growth of the smart pills market.
Major companies operating in the smart pills market are concentrating on the development of smart pills with customizable programs, including ingestible multi-sensor prototypes that support tailored drug delivery and in-vivo monitoring to improve treatment adherence and therapeutic outcomes. Customizable programs refer to firmware- or software-based control of sensing functions, data collection, and triggerable actions that clinicians or trial managers can configure for individual patients. For example, in 2025, the Interuniversity Microelectronics Centre, a Belgium-based research and innovation institute, introduced a prototype ingestible sensor for gut health monitoring that integrates multiple sensing modalities chemical, mechanical, and electrical along with onboard signal processing, power management, and real-time data transmission for remote monitoring. The prototype focuses on miniaturization and full-system integration to enable configurable sensing programs for personalized clinical applications.
Major companies operating in the smart pills market are Medtronic plc, Olympus Corporation, CapsoVision Inc., Novartis AG, Proteus Digital Health Inc., Koninklijke Philips N.V., MicroCHIPS Inc., Bio-Images Drug Delivery (BDD) Ltd., Given Imaging Ltd., Vitality Inc., Boston Scientific Corporation, HQ Inc., Fujifilm Holdings Corporation, General Electric Company, Check-Cap Ltd., IntroMedic Co. Ltd., Jinshan Science & Technology Co. Ltd., PENTAX Medical, etectRx Inc., Pixie Scientific HQ Inc., ANX Robotica Corp., RF Co. Ltd., Shenzhen Jifu Medical Technology Co. Ltd., Otsuka America Pharmaceutical Inc., Medimetrics Personalized Drug Delivery B.V., Smart Pill Inc., Medisafe Inc., AdhereTech LLC, TabSafe Medical Services Inc.
North America was the largest region in the smart pills market in 2025. Western Europe was the second-largest region in the smart pills market analysis. The regions covered in the smart pills market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the smart pills market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the smart pills market by increasing costs of imported microelectronics, sensors, transmitters, and pharmaceutical-grade materials used in ingestible devices. Healthcare providers and research institutions in North America and Europe are most affected due to reliance on imported electronic components, while Asia-Pacific faces cost pressure on device manufacturing and exports. These tariffs are raising development and production costs and slowing commercialization timelines. However, they are also encouraging localized electronics manufacturing, domestic R&D investments, and regional partnerships to advance smart pill innovation.
The smart pills market research report is one of a series of new reports that provides smart pills market statistics, including smart pills industry global market size, regional shares, competitors with a smart pills market share, detailed smart pills market segments, market trends and opportunities, and any further data you may need to thrive in the smart pills industry. This smart pills market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Smart pills are designed for the purpose of administering medication and are equipped with electronic sensors that emit signals detectable by patches or smartphones upon ingestion. These innovative pills play a crucial role in ensuring patients' adherence to their prescribed drug regimens and enable the monitoring of medication compliance.
The primary applications of smart pills encompass capsule endoscopy, patient monitoring, and drug delivery. Patient monitoring involves the repeated or continuous tracking of various patient parameters. Smart pills are used to target specific areas within the gastrointestinal tract, including the esophagus, stomach, small intestine, and large intestine, for the treatment of conditions such as esophageal diseases, colon diseases, small bowel diseases, among others. These smart pills find utility in a variety of healthcare settings, including hospitals, diagnostic centers, and research institutes.
The smart pills market consists of sales of instruments that are used in applications such as capsule endoscopy, drug delivery, and patient monitoring. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Smart Pills Market Characteristics
3. Smart Pills Market Supply Chain Analysis
4. Global Smart Pills Market Trends and Strategies
5. Smart Pills Market Analysis of End Use Industries
7. Global Smart Pills Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Smart Pills Total Addressable Market (TAM) Analysis for the Market
9. Smart Pills Market Segmentation
10. Smart Pills Market Regional and Country Analysis
11. Asia-Pacific Smart Pills Market
12. China Smart Pills Market
13. India Smart Pills Market
14. Japan Smart Pills Market
15. Australia Smart Pills Market
16. Indonesia Smart Pills Market
17. South Korea Smart Pills Market
18. Taiwan Smart Pills Market
19. South East Asia Smart Pills Market
20. Western Europe Smart Pills Market
21. UK Smart Pills Market
22. Germany Smart Pills Market
23. France Smart Pills Market
24. Italy Smart Pills Market
25. Spain Smart Pills Market
26. Eastern Europe Smart Pills Market
27. Russia Smart Pills Market
28. North America Smart Pills Market
29. USA Smart Pills Market
30. Canada Smart Pills Market
31. South America Smart Pills Market
32. Brazil Smart Pills Market
33. Middle East Smart Pills Market
34. Africa Smart Pills Market
36. Smart Pills Market Competitive Landscape and Company Profiles
37. Smart Pills Market Other Major and Innovative Companies
40. Smart Pills Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Smart Pills Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses smart pills market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for smart pills? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart pills market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Target Area: Esophagus; Stomach; Small Intestine; Large Intestine2) By Disease Indication: Esophageal Diseases; Colon Diseases; Small bowel Diseases; And Other Disease Indications
3) By Application: Capsule Endoscopy; Patient Monitoring; Drug Delivery
4) By End User: Hospital; Diagnostic Center; Research Institute
Subsegments:
1) By Esophagus: Diagnostic Pills For Esophageal Disorders; Pills For Monitoring Esophageal Motility2) By Stomach: Gastric Emptying Monitoring Pills; Diagnostic Pills For Gastric Disorders
3) By Small Intestine: Pills For Absorption Studies; Diagnostic Pills For Small Bowel Diseases
4) By Large Intestine: Colonoscopy Alternative Pills; Pills For Detecting Colorectal Disorders
Companies Mentioned: Medtronic plc; Olympus Corporation; CapsoVision Inc.; Novartis AG; Proteus Digital Health Inc.; Koninklijke Philips N.V.; MicroCHIPS Inc.; Bio-Images Drug Delivery (BDD) Ltd.; Given Imaging Ltd.; Vitality Inc.; Boston Scientific Corporation; HQ Inc.; Fujifilm Holdings Corporation; General Electric Company; Check-Cap Ltd.; IntroMedic Co. Ltd.; Jinshan Science & Technology Co. Ltd.; PENTAX Medical; etectRx Inc.; Pixie Scientific HQ Inc.; ANX Robotica Corp.; RF Co. Ltd.; Shenzhen Jifu Medical Technology Co. Ltd.; Otsuka America Pharmaceutical Inc.; Medimetrics Personalized Drug Delivery B.V.; Smart Pill Inc.; Medisafe Inc.; AdhereTech LLC; TabSafe Medical Services Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Smart Pills market report include:- Medtronic plc
- Olympus Corporation
- CapsoVision Inc.
- Novartis AG
- Proteus Digital Health Inc.
- Koninklijke Philips N.V.
- MicroCHIPS Inc.
- Bio-Images Drug Delivery (BDD) Ltd.
- Given Imaging Ltd.
- Vitality Inc.
- Boston Scientific Corporation
- HQ Inc.
- Fujifilm Holdings Corporation
- General Electric Company
- Check-Cap Ltd.
- IntroMedic Co. Ltd.
- Jinshan Science & Technology Co. Ltd.
- PENTAX Medical
- etectRx Inc.
- Pixie Scientific HQ Inc.
- ANX Robotica Corp.
- RF Co. Ltd.
- Shenzhen Jifu Medical Technology Co. Ltd.
- Otsuka America Pharmaceutical Inc.
- Medimetrics Personalized Drug Delivery B.V.
- Smart Pill Inc.
- Medisafe Inc.
- AdhereTech LLC
- TabSafe Medical Services Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 6.75 Billion |
| Forecasted Market Value ( USD | $ 10.13 Billion |
| Compound Annual Growth Rate | 10.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |
